JUN 04, 2021 3:15 PM PDT

Neurotechnology and Saliva Tests Detect Psychoactive Effects of Cannabis

WRITTEN BY: Annie Lennon

Researchers from contract research organization, KGK Science, working on behalf of neurotechnology firm Zentrela, have found that neurotechnology combined with saliva testing can more accurately indicate whether a person is experiencing psychoactive effects from cannabis use than traditional methods. 

Being able to correctly assess the psychoactive effects of THC is important for law enforcement, especially given the increasing legalization of cannabis. Doing so has traditionally relied on saliva, blood and urine samples. This comes despite some studies saying that there is no direct correlation between THC concentration levels in bodily fluids and the psychoactive effects of THC. 

For the study, the researchers recruited 75 participants aged between 19 and 55. They collected saliva samples from each prior consumption of cannabis. They also conducted an EEG on each patient and gave them a subjective drug effects questionnaire (DEQ) before and after cannabis inhalation. A second saliva sample was collected for the 50 participants who remained at the clinic four hours after inhaling the cannabis. 

EEG files of the participants were analyzed by Xentrala’s Cognalyzer® algorithm, a technology built to detect the presence of cannabis’ psychoactive effects from analyzing brain signals and machine learning. In particular, the algorithm examined the EEG files for sensitivity, specificity, accuracy, percent false positive, percent false negative and positive and negative predictive value. The researchers combined these results with analysis of saliva samples.

All in all, the researchers found that Cognalyzer® algorithm was over 80% accurate in predicting the psychoactive effects of cannabis. They further found that combining analysis from the Cognalyzer® algorithm with saliva concentrations of THC reduced false-positive fluid test results by up to 49%. 

Until this point, there simply hasn’t been an accurate, science-based test for quantifying cannabis psychoactive effects,” says Israel Gasperin, CEO of Zentrela, “We have clearly demonstrated that neuroscience powered by artificial intelligence (AI) can accurately detect and quantify the psychoactive effects of cannabis."

“This represents a huge potential for Zentrela to become the definitive source for specific, science-based data on cannabis product effects for the entire industry. And we are still at the beginning of our journey. There is no reason we cannot apply this proven neurotechnology to other drugs and industries.”

 

Sources: News MedicalCannabis Science TechAdvances in Therapy

 

 

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
DEC 29, 2020
Cannabis Sciences
What Happens When You Combine Cannabis with Psychedelics?
DEC 29, 2020
What Happens When You Combine Cannabis with Psychedelics?
Despite the growing popularity of cannabis and psychedelics, there is a shortage of research on how the two interact. Be ...
JAN 21, 2021
Health & Medicine
More Evidence Cannabis Can Calm a Cytokine Storm
JAN 21, 2021
More Evidence Cannabis Can Calm a Cytokine Storm
A new study out of Canada lends further evidence to the idea that cannabis components may help to calm the cytokine stor ...
MAY 04, 2021
Health & Medicine
Detecting Driving Impairment From Cannabis Use Is Extremely Tricky, Experts Say
MAY 04, 2021
Detecting Driving Impairment From Cannabis Use Is Extremely Tricky, Experts Say
Don’t drive high is a sensible message, but ultimately nobody really knows the impact of cannabis on an individual ...
MAY 04, 2021
Health & Medicine
Micro-dosing Inhaler Breakthrough for Medical Cannabis
MAY 04, 2021
Micro-dosing Inhaler Breakthrough for Medical Cannabis
In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is a ...
MAY 25, 2021
Health & Medicine
Randomized Controlled Trial Assessing Cannabis Use for Migraine Begins
MAY 25, 2021
Randomized Controlled Trial Assessing Cannabis Use for Migraine Begins
Cannabis has been used to soothe headaches since almost the dawn of time, but there have been few studies — and ce ...
JUN 05, 2021
Cannabis Sciences
Washington State University Opens Cannabis Research Center
JUN 05, 2021
Washington State University Opens Cannabis Research Center
Washington State University (WSU) has announced the opening of a multi-disciplinary research center with nearly 100 scie ...
Loading Comments...